Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited Woos Cipla Ltd. With $6 Billion Offer

Published: May 08, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

It’s the season for pharma deals, and the world’s largest maker of off-patent drugs, Israel’s Teva Pharmaceutical Industries Ltd, is wooing Cipla Ltd with an offer that is as high as $6 billion, people familiar with the matter said. The Israeli company, which is targeting revenue of $31 billion by 2015 (it also wants to reduce costs by $2 billion in the next two to three years) has since 2012 twice made approaches to the Indian drug maker. It was rebuffed both times.

Help employers find you! Check out all the jobs and post your resume.

Back to news